| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1460-9592.2010.03389.X |
| P698 | PubMed publication ID | 20723094 |
| P2093 | author name string | Francis Veyckemans | |
| Karel Allegaert | |||
| Alain Rochette | |||
| P2860 | cites work | Development of CYP2D6 and CYP3A4 in the first year of life | Q46878596 |
| Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants and children : how accurate are available scaling methods? | Q46906656 | ||
| Developmental changes in human liver CYP2D6 expression. | Q51957350 | ||
| A mechanistic approach for the scaling of clearance in children. | Q52013911 | ||
| Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother | Q28258937 | ||
| Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children | Q33998916 | ||
| Developmental pharmacology--drug disposition, action, and therapy in infants and children | Q34247047 | ||
| Scaling for size: some implications for paediatric anaesthesia dosing | Q34570931 | ||
| Ontogeny of dextromethorphan O- and N-demethylation in the first year of life | Q34575597 | ||
| The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis | Q35994975 | ||
| Use of tramadol in children | Q36329291 | ||
| Population clinical pharmacology of children: modelling covariate effects. | Q36522932 | ||
| Population clinical pharmacology of children: general principles. | Q36522936 | ||
| Mechanism-based concepts of size and maturity in pharmacokinetics | Q36960112 | ||
| Clinical practice: analgesia in neonates. | Q37394668 | ||
| Pediatric pharmacology in the first year of life | Q37548359 | ||
| Pro-con debate: is codeine a drug that still has a useful role in pediatric practice? | Q37671024 | ||
| Population pharmacokinetics of the two enantiomers of tramadol and O-demethyl tramadol after surgery in children. | Q39308073 | ||
| Apnea in a child after oral codeine: a genetic variant - an ultra-rapid metabolizer | Q39334234 | ||
| Population pharmacokinetic/pharmacodynamic modelling of the analgesic effects of tramadol in pediatrics | Q39346524 | ||
| Tramadol disposition in the very young: an attempt to assess in vivo cytochrome P-450 2D6 activity. | Q39365864 | ||
| Maturational pharmacokinetics of single intravenous bolus of propofol | Q42632668 | ||
| Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model | Q43137253 | ||
| Impact of CYP2D6 genotype on postoperative tramadol analgesia | Q44589963 | ||
| Developmental pharmacokinetics of morphine and its metabolites in neonates, infants and young children. | Q44727177 | ||
| Intravenous paracetamol (propacetamol) pharmacokinetics in term and preterm neonates | Q44835582 | ||
| Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. | Q44975275 | ||
| Human renal function maturation: a quantitative description using weight and postmenstrual age. | Q45281878 | ||
| In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age. | Q45983569 | ||
| Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis. | Q46401554 | ||
| Postmenstrual age and CYP2D6 polymorphisms determine tramadol o-demethylation in critically ill neonates and infants. | Q46720804 | ||
| Covariates of tramadol disposition in the first months of life. | Q46731606 | ||
| P433 | issue | 3 | |
| P921 | main subject | pharmacology | Q128406 |
| infancy stage | Q49257364 | ||
| P304 | page(s) | 266-273 | |
| P577 | publication date | 2010-08-17 | |
| P1433 | published in | Paediatric Anaesthesia | Q1921395 |
| P1476 | title | Developmental pharmacology of tramadol during infancy: ontogeny, pharmacogenetics and elimination clearance | |
| P478 | volume | 21 |
| Q58106372 | Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients? |
| Q33574126 | Changes in individual drug-independent system parameters during virtual paediatric pharmacokinetic trials: introducing time-varying physiology into a paediatric PBPK model |
| Q34399802 | Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. |
| Q33950874 | Clinical pharmacology in neonates: small size, huge variability |
| Q87042591 | Comment on: Pharmacokinetics of Tramadol and O-Desmethyltramadol Enantiomers Following Administration of Extended-Release Tablets to Elderly and Young Subjects |
| Q35800807 | Detection of an endogenous urinary biomarker associated with CYP2D6 activity using global metabolomics |
| Q26822946 | Development of biomarkers to optimize pediatric patient management: what makes children different? |
| Q48286613 | Developmental pharmacology; filling one knowledge gap in pediatric anesthesiology |
| Q91584992 | Dose-linearity of the pharmacokinetics of an intravenous [14 C]midazolam microdose in children |
| Q84779552 | Estimation of the minimum effective dose of tramadol for postoperative analgesia in infants using the continual reassessment method |
| Q37858446 | Mechanism based medicine in infancy: complex interplay between developmental pharmacology and pharmacogenetics. |
| Q26992019 | Neonatal clinical pharmacology |
| Q34081859 | Novel pharmacotherapeutic strategies for treatment of opioid-induced neonatal abstinence syndrome |
| Q37944353 | Pain, analgesia and genetics. |
| Q37958058 | Perioperative management of the child on long-term opioids |
| Q37892531 | Pharmacogenetics and individualized therapy in children: immunosuppressants, antidepressants, anticancer and anti-inflammatory drugs |
| Q40181637 | Pharmacogenomic information in FDA-approved drug labels: Application to pediatric patients |
| Q36452341 | Pharmacological treatment of neonatal pain: in search of a new equipoise |
| Q37872786 | Profound changes in drug metabolism enzymes and possible effects on drug therapy in neonates and children |
| Q38441114 | The Pharmacogenetics of Tramadol. |
| Q38161817 | The interplay between drugs and the kidney in premature neonates. |
| Q85640561 | Tramadol and o-desmethyl tramadol clearance maturation and disposition in humans: a pooled pharmacokinetic study |
| Q24187237 | Tramadol for postoperative pain treatment in children |
| Q47276375 | Tramadol: keep calm and carry on. |
| Q52349592 | When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children. |
Search more.